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Lyme disease is the most common tickborne illness in the world today. A recent study
describes for the first time an enzyme produced by the spirochetal agent of Lyme
disease, Borrelia burgdorferi, that cleaves aggrecan, a proteoglycan found in joints and
connective tissue. Discovery of the spirochetal aggrecanase raises many questions about
the pathogenesis of Lyme arthritis and lends support to the concept of persistent
B. burgdorferi infection in patients with chronic Lyme disease symptoms.
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Lyme disease is the most common tickborne illness in the world
today (Stricker and Johnson, 2011). As of July 2013, the Medline
database lists more than 25,000 published peer-reviewed arti-
cles about tickborne diseases. Despite this plethora of scientific
information, however, the pathogenetic mechanisms of rheuma-
tological, neurological and cardiac complications induced by the
Lyme spirochete, Borrelia burgdorferi, have not been fully eluci-
dated (Schmit et al., 2011; Lin et al., 2012). In particular, themode
of tissue invasion by the Lyme spirochete remains obscure.
In an elegant study of a potential mechanism of Lyme arthri-
tis, Russell and Johnson describe for the first time an enzyme
produced by B. burgdorferi that cleaves aggrecan, a proteogly-
can found in joints and connective tissue (Russell and Johnson,
2013). The spirochetal aggrecanase, called BbHtrA, was identi-
fied in the three major species of B. burgdorferi, was expressed
on the spirochete surface, and was shown to cleave aggrecan at a
site that destroys the function of the proteoglycan. Furthermore,
and perhaps of greatest importance, the proteoglycan degrada-
tion fragments produced by BbHtrA cleavage have been detected
in the synovial fluid of patients with Lyme arthritis. These obser-
vations suggest that the spirochetal enzyme plays a role in the
rheumatological pathology of Lyme disease (Russell and Johnson,
2013).
Although the discovery of BbHtrA suggests a novel spirochetal
mechanism of Lyme arthritis, the involvement of aggrecanase
in this process is not novel. A previous study by Behera et al.
showed that B. burgdorferi may induce expression of ADAMTS-
4, a host tissue aggrecanase that can cleave the proteoglycan in
the joints of mice and humans (Behera et al., 2006). Thus, the
Lyme spirochete may induce joint damage using both host tissue
(ADAMTS-4) and spirochetal (BbHtrA) aggrecanases. Although
Russell and Johnson touch briefly on this point in their report,
the implications of the redundant enzyme activity merit further
discussion.
Aggrecanase activity has been associated with various forms
of arthritis and more recently with progression of degenerative
disc disease and aortic aneurysm dissection (Huang and Wu,
2008; Mimata et al., 2012; Tian et al., 2013; Zhang et al., 2013).
The principal tissue aggrecanases ADAMTS-4 and ADAMTS-5
appear to be regulated by inflammatory cytokines such as IL-6,
TNF-α and IL-1β, and these enzymes appear to work in tan-
dem to induce joint injury (Mimata et al., 2012; Tian et al.,
2013). Based on their ability to damage proteoglycans, the tis-
sue aggrecanases have been identified as potential therapeutic
targets in the prevention and treatment of arthritis and con-
nective tissue diseases (Huang and Wu, 2008; Mimata et al.,
2012; Ren et al., 2013; Tian et al., 2013; Zhang et al., 2013).
As pointed out by Russell and Johnson, secreted aggrecanases
from several gram-negative bacteria also appear to be involved
in tissue invasion and propagation of infection under vary-
ing stress conditions in the host (Wu et al., 2011; Hoy et al.,
2013).
The discovery of a spirochetal aggrecanase raises significant
questions about the mechanisms of joint and connective tissue
injury as well as tissue invasion by B. burgdorferi. How does this
pathogen-associated enzyme work in conjunction with the tissue
aggrecanases, and which one is dominant? How is the spirochetal
enzyme regulated, and specifically do inflammatory cytokines
influence expression of the spirochetal aggrecanase in the same
manner as the tissue enzymes? Are the aggrecan cleavage sites
the same for the tissue and spirochetal enzymes? Do tickborne
coinfections influence expression of the spirochetal aggrecanase,
as suggested by previous studies of tissue enzyme activity (Grab
et al., 2007)? And as with other bacteria that secrete a similar
aggrecanase, do these enzymes play a more general role in con-
nective tissue invasion by B. burgdorferi, including induction of
disease in other organ systems? The answers to these and related
questions will help to elucidate both the mechanisms of acute
Frontiers in Cellular and Infection Microbiology www.frontiersin.org August 2013 | Volume 3 | Article 40 | 1
CELLULAR AND INFECTION MICROBIOLOGY
Stricker and Johnson Borrelia burgdorferi aggrecanase
Lyme arthritis and the evolution of persistent infection with the
Lyme spirochete (Berndtson, 2013; Stricker and Johnson, 2013).
Controversy persists over the existence of chronic Lyme dis-
ease due to persistent infection with B. burgdorferi in patients
who are untreated or undertreated for the spirochetal illness
(Berndtson, 2013; Stricker and Johnson, 2013). While some
researchers continue to insist that there is no “credible sci-
entific evidence” for chronic Lyme disease, a growing body
of clinical and research evidence supports persistent symp-
tomatic infection with the Lyme spirochete (Miklossy, 2012;
Berndtson, 2013; Ljøstad and Mygland, 2013; Stricker and
Johnson, 2013). The discovery of a spirochetal aggrecanase that
damages tissues and enhances tissue invasion by B. burgdor-
feri adds support to the concept of persistent symptomatic
infection in Lyme disease. The extent to which this spirochetal
enzyme helps B. burgdorferi to penetrate tissue sites, evade the
immune response and survive antibiotic therapy remains to be
determined.
The study by Russell and Johnson is yet another reminder of
the complexity of B. burgdorferi pathogenesis (Salman-Dilgimen
et al., 2011; Chaconas, 2012; Chaconas andNorris, 2013). The fact
that the Lyme spirochete can apparently utilize its own enzyme as
well as hijacking a host enzyme to facilitate tissue invasion under-
scores the regulatory and molecular complexity of the spirochete,
which contains one of the “most unusual genomes on the planet”
(Chaconas, 2012). From a microbiological perspective, the study
of B. burgdorferi gene function is yielding fascinating clues about
the interaction of this organism with its host and the coordinated
interplay within its own genetic elements (Salman-Dilgimen
et al., 2011; Schmit et al., 2011; Chaconas, 2012; Chaconas and
Norris, 2013). Clearly we still have lots to learn about the science
of Lyme disease (Pearson and Huyshe-Shires, 2013).
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